Suncorporation ( (JP:6736) ) has shared an update.
SUNCORPORATION announced the receipt of 3,489,202 shares from its equity method affiliate, Cellebrite, due to a price adjustment clause following Cellebrite’s listing on NASDAQ. This share acquisition, which was free of charge, does not affect SUNCORPORATION’s operating profit projection, but it increases their total shares in Cellebrite to 10,467,606, reflecting strategic growth.
More about Suncorporation
SUNCORPORATION operates in the technology sector, focusing on equity investments in companies such as Cellebrite, which is involved in digital intelligence solutions. The company is listed on the TSE Standard and engages in strategic partnerships to enhance its market positioning.
YTD Price Performance: -5.72%
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.24B
For an in-depth examination of 6736 stock, go to TipRanks’ Stock Analysis page.